Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device

Inclusion Criteria: * Papulopustular rosacea of the cheeks * Ability to complete six weeks of twice-weekly treatments Exclusion Criteria: * substantial asymmetry of disease distribution * previous failure of topical ivermectin treatment * presence of any other facial dermatoses * presence of any photosensitizing disorders * systemic tetracycline, systemic or topical ivermectin treatment within 6 weeks of start date * current or within prior 3 months treatment with systemic immune-suppressive medication